How Are Targeted Cancer Therapies Driving Innovation in the...

أضاف وظيفة جديدة Networking

2026-03-16 06:27:42 - ترجمة

How Are Targeted Cancer Therapies Driving Innovation in the Hormone-Refractory Oncology Drug Market?

Demand Outlook for Executive Summary Hormone-Refractory Oncology Drug Market Market Size and Share CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period The wide-ranging report deals with the new business challenges and investment...

0 التعليقات 0 المشاركات 67 مشاهدة 0 معاينة